home > research channels > sectors > pharma > reports

 
Reports Archive   Year   
Date Title Pages Source Download
Mar-20 Key prescription trends this quarter   11 Nirmal Bang
Mar-20 Volume growth revives; Sustainability remains key monitorable   26 Motilal Oswal
Mar-20 IPM growth not yet impacted by Covid-19   10 Prabhudas Lilladher
Mar-20 Drugs and Pharma Update: February 2020   3 CARE Research
Feb-20 Volumes continue impacting overall growth   26 Motilal Oswal
Feb-20 Robust India drives Q3   6 HDFC Securities
Feb-20 DOJ’s new indictments, negative for Taro   5 IIFL
Feb-20 Domestic drives Q3; Aurobindo Unit IV receives VAI   16 ICICI direct.com
Feb-20 Cost rationalization remains the key for FY21   10 Emkay Research
Jan-20 Tepid volumes drag overall growth in Dec'19   26 Motilal Oswal
Jan-20 Sequentially weak profitability as compliance issues pile up   7 Ashika Stock Broking
Jan-20 Dec'19 IPM growth in line with expectations   10 Emkay Research
Jan-20 Q3 FY20 Preview   32 Anand Rathi
Jan-20 Tepid earnings growth; valuations buoyant   8 Edelweiss Securities
Jan-20 Steady Quarter   7 Centrum Research
Jan-20 Base business strengthening – Earnings continue to be range bound   4 Nirmal Bang